Company news
Champions Oncology, Inc. news in 2024
Champions Oncology, Inc.'s news releases, calls and decks from 2024, newest first.
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
December 10, 2024
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
December 4, 2024
Champions Oncology Announces Agreement with Weill Cornell Medicine
October 15, 2024
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
September 10, 2024
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
September 8, 2024
Champions Oncology Reports Quarterly Revenue of $14.0 Million
July 17, 2024
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024
July 10, 2024
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
June 3, 2024
Champions Oncology Reports Quarterly Revenue of $12.0 Million
March 11, 2024
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
March 6, 2024
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024
March 5, 2024
Calls in 2024
- Champions Oncology (NASDAQ:CSBR) Q2 2025 Earnings Call
Dec 11, 2024
Transcript - Champions Oncology (NASDAQ:CSBR) Q1 2025 Earnings Call
Sep 11, 2024
Transcript - Champions Oncology (NASDAQ:CSBR) Q4 2024 Earnings Call
Jul 18, 2024
Transcript - Champions Oncology (NASDAQ:CSBR) Q3 2024 Earnings Call
Mar 12, 2024
Transcript